Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line

Research output: Contribution to journalJournal articleResearchpeer-review


  • Fulltext

    Final published version, 2.71 MB, PDF document

  • Ozgür, Burak
  • Elena Puris
  • Andreas Brachner
  • Antje Appelt-Menzel
  • Sabrina Oerter
  • Viktor Balzer
  • Mikkel Roland Holst
  • Rasmus Folmann Christiansen
  • Kathrine Hyldig
  • Stephen T Buckley
  • Kristensen, Mie
  • Seppo Auriola
  • Allan Jensen
  • Gert Fricker
  • Morten Schallburg Nielsen
  • Winfried Neuhaus
  • Larsen, Birger Brodin

BACKGROUND: Blood-brain barrier (BBB) models based on primary murine, bovine, and porcine brain capillary endothelial cell cultures have long been regarded as robust models with appropriate properties to examine the functional transport of small molecules. However, species differences sometimes complicate translating results from these models to human settings. During the last decade, brain capillary endothelial-like cells (BCECs) have been generated from stem cell sources to model the human BBB in vitro. The aim of the present study was to establish and characterize a human BBB model using human induced pluripotent stem cell (hiPSC)-derived BCECs from the hIPSC line SBAD0201.

METHODS: The model was evaluated using transcriptomics, proteomics, immunocytochemistry, transendothelial electrical resistance (TEER) measurements, and, finally, transport assays to assess the functionality of selected transporters and receptor (GLUT-1, LAT-1, P-gp and LRP-1).

RESULTS: The resulting BBB model displayed an average TEER of 5474 ± 167 Ω·cm 2 and cell monolayer formation with claudin-5, ZO-1, and occludin expression in the tight junction zones. The cell monolayers expressed the typical BBB markers VE-cadherin, VWF, and PECAM-1. Transcriptomics and quantitative targeted absolute proteomics analyses revealed that solute carrier (SLC) transporters were found in high abundance, while the expression of efflux transporters was relatively low. Transport assays using GLUT-1, LAT-1, and LRP-1 substrates and inhibitors confirmed the functional activities of these transporters and receptors in the model. A transport assay suggested that P-gp was not functionally expressed in the model, albeit antibody staining revealed that P-gp was localized at the luminal membrane.

CONCLUSIONS: In conclusion, the novel SBAD0201-derived BBB model formed tight monolayers and was proven useful for studies investigating GLUT-1, LAT-1, and LRP-1 mediated transport across the BBB. However, the model did not express functional P-gp and thus is not suitable for the performance of drug efflux P-gp reletated studies.

Original languageEnglish
Article number96
JournalFluids and Barriers of the CNS
Issue number1
Number of pages15
Publication statusPublished - 2023

Bibliographical note

© 2023. The Author(s).

    Research areas

  • Humans, Animals, Cattle, Mice, Swine, Blood-Brain Barrier/metabolism, Induced Pluripotent Stem Cells/physiology, Cell Line, Biological Transport, Brain/metabolism, Membrane Transport Proteins/metabolism, Cells, Cultured

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 377828381